PHS Technologies Group LLC, a division of PACSHealth LLC, announced that it has been awarded a group purchasing agreement with Premier, Inc. for DoseMonitor, its radiation dose tracking system. 

Abbott announced clinically meaningful changes to quality of life, a reduction in rehospitalization for heart failure, and functional improvements for patients treated with the company's first-in-class, catheter-based MitraClip therapy for patients with degenerative mitral regurgitation (MR). Findings were presented at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in San Francisco and simultaneously published in the Journal of the American College of Cardiology.  

ct systems imaging american college of radiology sgr

The American College of Radiology (ACR) applauded a joint Senate Finance and House Committee on Ways and Means’ proposal to require ordering physicians to consult appropriateness criteria for advanced imaging services provided to Medicare patients.

The Boston Scientific Corp. Lotus Valve System met a performance measure in the treatment of symptomatic patients with severe aortic valve stenosis considered at high risk for surgical valve replacement, according to new data released at the 25th annual Transcatheter Cardiovascular Therapeutics scientific symposium (TCT 2013) in San Francisco.

Infraredx TVC Imaging System, Infraredx, TVC Imaging System

MedStar Heart Institute of Washington, D.C. and Infraredx, Inc. announced the initiation of the Lipid-Rich Plaque (LRP) Study, a prospective, multi-center study designed to evaluate the ability of intravascular imaging to identify patients with LRPs who are at a higher risk for heart attacks and other serious coronary events. 

MedCurrent Corp. will debut OrderRight 3.0 at the Radiological Society of North America’s Annual Meeting (RSNA), December 1-5, 2013 at Chicago’s McCormick Place. MedCurrent will exhibit in the South Hall, booth #3106.

According to a study of diabetic patients who underwent revascularization for multivessel coronary artery disease (CAD), patients treated with insulin experienced more major adverse cardiovascular events after revascularization than those not treated with insulin.

A new study demonstrated that some patients may not need to receive prolonged anti-clotting therapy after drug-eluting stent (DES) implantation with the Endeavor zotarolimus-eluting stent, and that shortening the duration could reduce bleeding risks and treatment costs.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now